ClinicalTrials.Veeva

Menu
F

FAICIC Clinical Research | Veracruz, Mexico

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
Ritonavir
PF-07321332
Gemcitabine
MK-3475-630
paclitaxel

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 6 total trials

A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)

The current study will compare pembrolizumab (MK-3475) plus maintenance olaparib, vs. pembrolizumab plus maintenance olaparib placebo for the treatme...

Active, not recruiting
Carcinoma, Squamous Cell, Non-small-cell Lung
Drug: Olaparib
Drug: Paclitaxel

This is a randomized, double-blind, study that compares pembrolizumab (MK-3475) with placebo given as adjuvant therapy in participants with high-risk...

Active, not recruiting
Carcinoma, Squamous Cell
Drug: Placebo
Biological: Pembrolizumab 400 mg

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Pfizer logo
Incyte logo
NovoCure logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems